Agenus Inc risk profile

44 Elevated one input has moved against it

Measured 1 September 2026 from AGEN's filed statements. Recomputed nightly.

44 (Elevated), driven by Cash conversion at 100, over 5 weighted categories on the MANUFACTURER profile.

What is measured

MechanismReadingBandDirectionDriver
Market expectation49ElevatedVolatileOne-year price volatility — 117.6%
Operating pressure0ContainedEasingCosts outgrowing revenue — -51.2 percentage points
Cash conversion100AcuteStableCapital spending against operating cash — -0.00x
Leverage and coverage100AcuteWorseningNet debt to EBITDA
Competitive position33NormalStableRevenue-growth gap against peers — -2.8 percentage points
ConcentrationReads identified supplier spend, customers above the 10% disclosure threshold and revenue by region. No reading is stored for this company.

These are descriptive readings of disclosed mechanisms, not investment advice, and not a prediction. A band says where a measured input sits, never what to do about it or what happens next.

Healthcare companies with a risk reading

Financials, valuation and price history for Agenus Inc